When I decided to use this blog to track the journey of Dying Is My Business toward publication for all you budding writers and other interested folks out there, I promised to detail the good and the bad. Today, the developments are on the bad side. Publishers Weekly, one of the book business’s major trade publications, has released the first pre-publication review of the novel, and it isn’t exactly complimentary:
Dying Is My Business
Nicholas Kaufmann. St. Martin’s Griffin, $15.99 trade paper (368p) ISBN 978-1-250-03610-0
Now, the last time Publishers Weekly gave me a bad review it was for Chasing the Dragon, which went on to be nominated for two major literary awards and rack up dozens of five-star raves, so I’m not too concerned. Still, a positive review is always more welcome than a negative one, so I’m a little bummed. For whatever reason, PW just doesn’t seem to like my stuff. I have to accept that and not let it trip me up.
And of course I can always console myself with this list of amazing advance blurbs from nine awesome authors!
Having a thick skin is an important part of this crazy business. It’s so easy to be discouraged by any little thing, and a bad review can be doubly discouraging because it can feel like if one reviewer doesn’t like it, nobody will like it. Plus, every writer I know already suffers from the Impostor Syndrome. A bad review can validate that particular neurosis and make an author say to him- or herself, “See? It was only a matter of time before everyone realized I’m a fraud.” But bad reviews are part of the business. All any writer worth his or her salt can do is soldier on. Because if writing is what you want to do, what other choice is there?